Differential modulation of the induction of inflammatory mediators by antibiotics in mouse macrophages in response to viable Gram-positive and Gram-negative bacteria

Journal of Endotoxin Research

Volumn 9, Issue 4, 2003, Pages 225-236

  Cui, Wei ^a,c   Lei, Mei Guey ^a   Silverstein, Richard ^b   Morrison, David C ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c STOWERS INSTITUTE FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BACTERIUM LIPOPOLYSACCHARIDE; BETA LACTAM ANTIBIOTIC; CEFTAZIDIME; CELL MEMBRANE PROTEIN; IMIPENEM; MESSENGER RNA; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIUM CULTURE; CELL ACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INCUBATION TIME; INFLAMMATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN SECRETION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTI-BACTERIAL AGENTS; AZTREONAM; CEFTAZIDIME; CELLS, CULTURED; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; ESCHERICHIA COLI; FEMALE; IMIPENEM; INFLAMMATION MEDIATORS; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C3H; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RNA, MESSENGER; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 0038448256     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225001422     Document Type: Article

References (48)

1. Bone RC. The pathogenesis of sepsis. Ann Intern Med 1991; 115: 457-469.
2. Leeson MC, Morrison DC. Induction of proinflammatory responses in human monocytes by particulate and soluble forms of lipopolysaccharide. Shock 1994; 2: 235-245.
3. Silverstein R, Wood JG, Xue Q, Norimatsu M, Horn DL, Morrison DC. Differential host inflammatory responses to viable vs. antibiotic-killed bacteria in experimental microbial sepsis. Infect Immun 2000; 68: 2301-2308.
4. Morrison DC, Silverstein R, Luchi M, Shnyra A. Structure-function relationships of bacterial endotoxins. In: Brade H, Opal SM, Vogel SN, Morrison DC. (eds) Endotoxin in Health and Disease, vol. 13. New York: Dekker, 1999; 313-340.
5. Muller-Alouf H, Alouf JE, Gerlach D, Ozegowski JH, Fitting C, Cavaillon J-M. Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide. Infect Immun 1994; 62: 4915-4921.
6. De Kimpe SJ, Kengatharan M, Thiemermann C, Vane JR. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc Natl Acad Sci USA 1995; 92: 10359-10363.
7. Heumann D, Barras C, Severin A, Glauser MP, Tomasz A. Gram-positive cell walls stimulate synthesis of tumor necrosis factor alpha and interleukin-6 by human monocytes. Infect Immun 1994; 62: 2715-2721.
8. Kengatharan KM, De Kimpe SJ, Robson C, Foster SJ, Thiemermann C. Mechanism of Gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock and multiple organ failure. J Exp Med 1998; 188: 305-315.
9. Mattsson E, Rollof J, Verhoef J, Van Dijk H, Fleer A. Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors. Infect Immun 1994; 62: 3837-3843.
10. Timmerman CP, Mattsson E, Martinez L et al. Induction of release of tumor necrosis factor from human monocytes by Staphylococci and Staphylococcal peptidoglycan. Infect Immun 1993: 61: 4167-4172.
11. Heeg K, Sparwasser T, Lipford GB, Hacker H, Zimmermann S, H. Wagner H. Bacterial DNA as an evolutionary conserved ligand signaling danger of infection to immune cells. Eur J Clin Microbiol Infect Dis 1998; 17: 464-469.
12. Sparwasser T, Miethke T, Lipford G et al. Macrophages sense pathogens via DNA motifs: induction of tumor necrosis factor-alpha-mediated shock. Eur J Immunol 1997; 27: 1671-1679.
13. Gao JJ, Zuvanich EG, Xue Q, Horn DL, Silverstein R, Morrison DC. Bacterial DNA and Upopolysaccharide act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J Immunol 1999; 163: 4095-4099.
14. Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time? Crit Care Med 1998; 26: 2078-2086.
15. Horn DL, Opal SM, Lomastro E. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis. Scand J Infect Dis Suppl 1996; 101: 9-13.
16. Goto H., Nakamura S. Liberation of endotoxin from Escherichia coli by addition of antibiotics. Jpn J Exp Med 1980; 50: 35-43.
17. Cohen J, McConnell JS. Release of endotoxin from bacteria exposed to ciprofloxacin and its prevention with polymyxin B. Eur J Clin Microbiol 1986; 5: 13-17.
18. Shenep JL, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental Gram-negative bacterial sepsis. J Infect Dis 1985: 151: 1012-1018.
19. Rokke O, Revhaug A, Osterud B, Giercksky KE. Increased plasma levels of endotoxin and corresponding changes in circulatory performance in a porcine sepsis model: the effect of antibiotic administration. Prog Clin Biol Res 1988: 272: 262-274.
20. Prins JM, van Agtmael MA, Kuijper EJ, van Deventer SJH, Speelman P. Antibiotic-induced endotoxin release in patients with Gram-negative urosepsis: a double-blind study comparing imipenem and ceftazidime. J Infect Dis 1995; 172: 886-891.
21. Luchi M, Morrison DC, Opal S et al. and the Urosepsis Study Group. A comparative trial of imipenem versus ceftazidime in the release of endotoxin and cytokine generation in patients with Gram-negative urosepsis. J Endotoxin Res 2000; 6: 25-31.
22. Simon DM, Koenig G, Trenholme GM. Differences in release of TNF from THP-1 cells stimulated by filtrates of antibiotic-killed E. coli. J Infect Dis 1991; 164: 800-2.
23. Opal SM, Horn DL, Palardy JE, Parejo N, Nhung J. The in vivo significance of antibiotic-induced endotoxin release in experimental Gram-negative sepsis. J Endotoxin Res 1996; 3: 245-252.
24. Bucklin SE, Morrison DC. Differences in therapeutic efficacy among cell wall-active antibiotics in a mouse model of Gram-negative sepsis. J Infect Dis 1995; 172: 1519-1527.
25. Dofferhoff ASM, Nijland JH, deVries-Hospers HG, Mulder POM, Weits J, Bom J. Effects of different types and combinations of antimicrobial agents on endotoxin release from Gram-negative bacteria - in vitro and in vivo study. Scand J Infect Dis 1991; 23: 745-754.
26. Periti P, Mazzei T. Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. J Chemother 1998; 10: 427-448.
27. Jackson JJ, Kropp H. Beta-lactam antibiotic-induced release of free endotoxin: in vitro comparison of penicillin-binding protein (PBP)-2-specific imipenem and PBP-s-specific ceftazidime. J Infect Dis 1992; 165: 1033-1041.
28. Bucklin SE, Fujihara Y, Leeson MC, Morrison DC. Differential antibiotic-induced release of endotoxin from Gram-negative bacteria. Eur J Clin Microbiol Infect Dis 1994; 13 (Suppl 1): S43-S51.
29. Barrett JF, Shockmann GD. Isolation and characterization of soluble peptidoglycan from several strains of Streptococcus faecium. J Bacteriol 1984; 159: 511-519.
30. Home D, Tomasz A. Release of lipoteichoic acid from Streptococcus sanguis: stimulation of release during penicillin treatment. J Bacteriol 1979; 137: 1180-1184.
31. Utsui Y, Ohya Y, Takenouchi Y et al. Release of lipoteichoic acid from Staphylococcus aureus by treatment with cefmetazole and other beta-lactam antibiotics. J Antibiot (Tokyo) 1983; 36: 1380-1386.
32. van Langevelde P, van Dissel JP, Ravensbergen E, Appelmelk BJ, Schrijver IA, Groeneveld PHP. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivates. Antimicrob Agents Chemother 1998; 42: 3073-3078.
33. van Langevelde P, Ravensbergen E, Grashoff P, Beekhuizen H, Groeneveld PHP, van Dissel JP. Antibiotic-induced cell wall fragments of Staphylococcus aureus increase endothelial chemokine secretion and adhesiveness for granulocytes. Antimicrob Agents Chemother 1999; 43: 2984-2989.
34. Cui W, Morrison DC, Silverstein R. Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating Gram-positive versus Gram-negative bacteria. Infect Immun 2000; 68: 4422-4429.
35. Silverstein R, Norimatsu M, Morrison DC. Fundamental differences during Gram-positive versus Gram-negative sepsis become apparent during bacterial challenge of D-galactosamine-treated mice. J Endotoxin Res 1997; 4: 173-181.
36. Croxton FE. Elementary Statistics with Application in Medicine, vol. 326. Englewood Cliff, NJ: Princeton-Hall, 1953; 235.
37. Beutler B. Application of transcriptional and post-transcriptional reporter constructs to the analysis of tumor necrosis factor gene regulation. Am J Med Sci 1992; 303: 129-133.
38. Biragyn A, Nedospasov SA. Lipopolysaccharide-induced expression of TNF-α gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity. J Immunol 1995; 155: 674-683.
39. MacMicking J, Xie QW, C. Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997; 15: 323-350.
40. Pace JL, Lowenstein CJ, Phillips TA et al. Population dynamics of inducible nitric oxide synthase production by LPS-and LPS/IFN-γ-stimulated mouse macrophages. J Endotoxin Res 1994; 1: 227-233.
41. Norimatsu M, Morrison DC. Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli-inoculated mouse whole blood ex vivo. J Infect Dis 1998; S177: 1302-1307.
42. Soto A, Evans J, Cohen J. Proinflammatory cytokine production by human peripheral blood mononuclear cells stimulated with cell-free supernatants of viridans streptococci. Cytokine 1996; 8: 300-304.
43. Amura CR, Kamei T, Ito N, Soares MJ, Morrison DC. Diffierential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. J Immunol 1998; 161: 2551-2560.
44. Kopp EB, Medzhitov R. The Toll-receptor family and control of innate immunity. Curr Opin Immunol 1999; 11: 13-28.
45. Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Repurification of lipopolysaccharide eliminates signaling through both human and murine Toll-like receptor 2. J Immunol 2000; 165: 618-622.
46. Krieg AM, Yi AK, Matson S et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 1995; 374: 546-549.
47. Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol 1996; 157: 2116-2122.
48. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol 2001; 167: 1882-1885.